Atlas Trials

In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides

Clinical trial NCT02159937 · COMPLETED

Trial details

NCT number
NCT02159937
Sponsor
Recepta Biopharma
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Cancer
Start date
2014-05-01
Primary completion
2014-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.